HCA Healthcare (NYSE:HCA) Price Target Lowered to $370.00 at KeyCorp

HCA Healthcare (NYSE:HCA) had its price target lowered by KeyCorp from $420.00 to $370.00 in a research note issued to investors on Tuesday morning,Benzinga reports. The firm currently has an overweight rating on the stock.

Several other equities research analysts have also recently commented on HCA. StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. Morgan Stanley cut their target price on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. Truist Financial lowered their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a report on Monday. Finally, Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their price target for the company from $400.00 to $320.00 in a report on Monday, November 25th. One analyst has rated the stock with a sell rating, three have given a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $385.27.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $308.55 on Tuesday. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. HCA Healthcare has a 1 year low of $276.50 and a 1 year high of $417.14. The business has a fifty day simple moving average of $324.68 and a 200 day simple moving average of $354.48. The firm has a market cap of $78.15 billion, a price-to-earnings ratio of 13.85, a P/E/G ratio of 1.21 and a beta of 1.64.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were given a $0.66 dividend. The ex-dividend date of this dividend was Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.86%. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

Insider Activity

In other news, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.70% of the company’s stock.

Institutional Investors Weigh In On HCA Healthcare

A number of large investors have recently bought and sold shares of HCA. Benjamin F. Edwards & Company Inc. acquired a new stake in shares of HCA Healthcare in the second quarter valued at $33,000. Legacy Investment Solutions LLC bought a new position in shares of HCA Healthcare in the third quarter worth about $39,000. Canoe Financial LP acquired a new stake in shares of HCA Healthcare in the third quarter valued at approximately $41,000. Capital Performance Advisors LLP acquired a new position in HCA Healthcare during the 3rd quarter worth $41,000. Finally, Northwest Investment Counselors LLC acquired a new stake in shares of HCA Healthcare in the 3rd quarter valued at $44,000. 62.73% of the stock is currently owned by institutional investors.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.